CRSP
#1261
CRISPR Therapeutics AG - Common Shares
59.3 7 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.24%
Changement Mensuel
+25.20%
Evolution sur 6 mois
+2.29%
Changement Annuel
+12.08%
Clôture Précédente
59.2 3
Open
59.3 7
Low
59.3 7
High
59.3 7
Volume
116
Financials
- Market Capitalization 5.74 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.11
ratio cours/chiffre d'affaires
1 343.5
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1229 |  PTCT PTC Therapeutics, Inc. - Common Stock | 71.81 USD | -1.21% | +1.80% | -4.06% | +44.14% | 5.99 B USD | ||
| 1245 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.82 USD | +0.11% | -4.51% | +4.33% | +190.01% | 5.89 B USD | ||
| 1272 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.52 USD | -1.16% | -1.24% | -3.43% | +52.05% | 5.67 B USD | ||
| 1341 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.73 USD | +0.51% | +2.24% | +13.82% | +13.52% | 5.12 B USD |